Nadler; Lee M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nadler; Lee M..The latest application filed is for "novel forms of t cell costimulatory molecules and uses therefor".

Company Profile

0.27.22

Nadler; Lee M. - Newton MA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tumor cells with increased immunogenicity and uses therfor Grant 8,026,224 - Ostrand-Rosenberg , et al. September 27, 2	2011-09-27
Modified antigen-presenting cells Grant 7,955,845 - Hirano , et al. June 7, 2	2011-06-07
Cancer immunotherapy and diagnosis using universal tumor associated antigens, including hTERT Grant 7,851,591 - Nadler , et al. December 14, 2	2010-12-14
Nucleic acids encoding CD100 molecules Grant 7,700,102 - Hall , et al. April 20, 2	2010-04-20
Nucleic acid molecules encoding B7-1 Grant 7,619,078 - Sharpe , et al. November 17, 2	2009-11-17
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies Grant 7,592,007 - Gribben , et al. September 22, 2	2009-09-22
Nucleic acids encoding B7-2 fusion proteins Grant 7,459,544 - Freeman , et al. December 2, 2	2008-12-02
Cancer immunotherapy and diagnosis using cytochrome P450 1B1 Grant 7,385,023 - Schultze , et al. June 10, 2	2008-06-10
Novel forms of T cell costimulatory molecules and uses therefor App 20070106070 - Sharpe; Arlene H. ; et al.	2007-05-10
Methods of inducing a T cell mediated immune response by administering antigen presenting B cells Grant 7,195,758 - Schultze , et al. March 27, 2	2007-03-27
Methods Of Inducing A T Cell Mediated Immune Response By Administering Antigen Presenting B Cells App 20070031811 - Schultze; Joachim L. ; et al.	2007-02-08
T cell costimulatory polypeptides containing alternative domains Grant 7,153,934 - Sharpe , et al. December 26, 2	2006-12-26
Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cells App 20060233795 - Freeman; Gordon J. ; et al.	2006-10-19
Tumor cells with increased immunogenicity and uses therfor App 20060099195 - Ostrand-Rosenberg; Suzanne ; et al.	2006-05-11
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor App 20050129670 - Freeman, Gordon J. ; et al.	2005-06-16
pH-triggered microparticles App 20050123596 - Kohane, Daniel S. ; et al.	2005-06-09
Modified antigen-presenting cells App 20050003484 - Hirano, Naoto ; et al.	2005-01-06
Methods for inhibiting the interaction of B7-2 with its natural ligand Grant 6,824,779 - Freeman , et al. November 30, 2	2004-11-30
Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligands App 20040230051 - Freeman, Gordon J. ; et al.	2004-11-18
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA-4 specific antibodies App 20040202650 - Gribben, John G. ; et al.	2004-10-14
B-7 domain-specific antibodies App 20040192899 - Sharpe, Arlene H. ; et al.	2004-09-30
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor Grant 6,723,705 - Freeman , et al. April 20, 2	2004-04-20
Methods of inhibiting T cell proliferation or IL-2 accumulation with CTLA4- specific antibodies Grant 6,719,972 - Gribben , et al. April 13, 2	2004-04-13
Methods for modulating T cell responses by manipulating a commom cytokine receptor gamma-chain App 20040037808 - Boussiotis, Vassiliki A. ; et al.	2004-02-26
Polypeptides comprising a B7 extracellular domain Grant 6,653,444 - Freeman , et al. November 25, 2	2003-11-25
DNA encoding B7, a new member of the Ig superfamily with unique expression on activated and neoplastic B cells App 20030170821 - Freeman, Gordon J. ; et al.	2003-09-11
Nucleic acids encoding CD100 molecules App 20030158402 - Hall, Kathryn T. ; et al.	2003-08-21
B7-specific antibodies Grant 6,608,180 - Sharpe , et al. August 19, 2	2003-08-19
Therapeutic compositions for inhibiting the interactions of B7-1 and B7-2 with their natural ligands Grant 6,605,279 - Freeman , et al. August 12, 2	2003-08-12
Tumor cells with increased immunogenicity and uses therefor App 20030124103 - Ostrand-Rosenberg, Suzanne ; et al.	2003-07-03
CD100 antigen and uses therefor Grant 6,576,754 - Hall , et al. June 10, 2	2003-06-10
Methods for stimulating T cell responses by manipulating a common cytokine receptor .gamma. chain Grant 6,576,236 - Boussiotis , et al. June 10, 2	2003-06-10
Nucleic Acids Encoding Cd100 Molecules App 20030044416 - HALL, KATHRYN T. ; et al.	2003-03-06
Novel forms of T cell costimulatory molecules and uses therefor App 20030045703 - Sharpe, Arlene H. ; et al.	2003-03-06
Methods for selectively modulating a Th2-type response within a population of activated CD4+ T cells App 20020182727 - Freeman, Gordon J. ; et al.	2002-12-05
Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin Grant 6,465,251 - Schultze , et al. October 15, 2	2002-10-15
Methods for inhibiting T cell responses by manipulating a common cytokine receptor gamma-chain App 20020127201 - Boussiotis, Vassiliki A. ; et al.	2002-09-12
Novel forms of T cell costimulatory molecules and uses therefor App 20020098542 - Sharpe, Arlene H. ; et al.	2002-07-25
Novel Ctla4/cd28 Ligands And Uses Therefor App 20020086414 - FREEMAN, GORDON J. ; et al.	2002-07-04
Tumor cells with increased immunogenicity and uses therefor App 20020086421 - Ostrand-Rosenberg, Suzanne ; et al.	2002-07-04
Methods for modulating T cell unresponsiveness App 20020051784 - Boussiotis, Vassiliki A. ; et al.	2002-05-02
Tumor cells with increased immunogenicity and uses therefor Grant 6,319,709 - Ostrand-Rosenberg , et al. November 20, 2	2001-11-20
Tumor cells with increased immunogenicity and uses therefor Grant 6,149,905 - Ostrand-Rosenberg , et al. November 21, 2	2000-11-21
Fusion proteins of novel CTLA4/CD28 ligands and uses therefore Grant 6,130,316 - Freeman , et al. October 10, 2	2000-10-10
CTLA4/CD28 ligands and uses therefor Grant 6,084,067 - Freeman , et al. July 4, 2	2000-07-04
DNA encoding, B7, a new member of the IG superfamily with unique expression on activated and neoplastic B cells Grant 6,071,716 - Freeman , et al. June 6, 2	2000-06-06
B7-2: a CTLA4/CD28 ligand Grant 5,942,607 - Freeman , et al. August 24, 1	1999-08-24
Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor Grant 5,861,310 - Freeman , et al. January 19, 1	1999-01-19
Tumor cells with increased immunogenicity and uses therefor Grant 5,858,776 - Ostrand-Rosenberg , et al. January 12, 1	1999-01-12